Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 54368-61-5 | MDL No. : | MFCD00831638 |
Formula : | C7H5Cl2N3O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CXMOEGSGXAUCNZ-UHFFFAOYSA-N |
M.W : | 266.04 | Pubchem ID : | 2761044 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 56.96 |
TPSA : | 97.9 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.14 cm/s |
Log Po/w (iLOGP) : | 1.51 |
Log Po/w (XLOGP3) : | 2.51 |
Log Po/w (WLOGP) : | 1.87 |
Log Po/w (MLOGP) : | 0.1 |
Log Po/w (SILICOS-IT) : | 0.32 |
Consensus Log Po/w : | 1.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.08 |
Solubility : | 0.219 mg/ml ; 0.000824 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.21 |
Solubility : | 0.0163 mg/ml ; 0.0000614 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -2.75 |
Solubility : | 0.475 mg/ml ; 0.00179 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With tin(II) chloride dihdyrate In ethyl acetate at 70℃; for 5 h; Sealed tube | A suspension of ethyl 2,6-dichloro-5-nitropyrimidine-4-carboxylate (1 g, 3.76 mmol, 1.00 equiv) and stannous chloride dihydrate (3.38 g, 14.98 mmol, 1.00 equiv) in ethyl acetate (30 mL) in a 50-mL sealed tube was stirred for 5 hours at 70° C. The resulting solution was diluted with 50 mL of water, the pH value of the solution was adjusted to 9 with sodium carbonate, extracted with 3*100 mL of ethyl acetate, washed with water and brine, dried over anhydrous sodium sulfate, and concentrated under vacuum. The residue was purified by a silica gel column with ethyl acetate/petroleum ether (1:5) to give the title compound (572 mg, 64percent) as a light yellow solid. LC-MS (ES, m/z): 236 [M+H]+. |
64% | With tin(II) chloride dihdyrate In ethyl acetate at 70℃; for 5 h; Sealed tube | A suspension of ethyl 2,6-dichloro-5-nitropyrimidine-4-carboxylate (1 g, 3.76 mmol, 1.00 equiv)and stannous chloride dihydrate (3.38 g, i4.98 mmol, 1.00 equiv) in ethyl acetate (30 mL) in a50-mL sealed tube was stirred for 5 hours at 70 °C. The resulting solution was diluted with 50 mLof water, the pH value of the solution was adjusted to 9 with sodium carbonate, extracted with3x 100 mL of ethyl acetate, washed with water and brine, dried over anhydrous sodium sulfate, and concentrated under vacuum. The residue was purified by a silica gel column with ethyl acetate/petroleum ether (1:5) to give the title compound (572 mg, 64percent) as a light yellow solid. LC-MS (ES, mlz): 236 [M+H]. |
[ 54368-62-6 ]
Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.85
[ 502184-51-2 ]
Methyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.82
[ 13162-26-0 ]
2,4-Dichloro-6-methyl-5-nitropyrimidine
Similarity: 0.79
[ 49845-33-2 ]
2,4-Dichloro-5-nitropyrimidine
Similarity: 0.72
[ 51940-63-7 ]
Ethyl 6-chloropyrimidine-4-carboxylate
Similarity: 0.69
[ 54368-62-6 ]
Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.85
[ 502184-51-2 ]
Methyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.82
[ 51940-63-7 ]
Ethyl 6-chloropyrimidine-4-carboxylate
Similarity: 0.69
[ 1160248-06-5 ]
Ethyl 8-chloroimidazo[1,5-a]pyrazine-1-carboxylate
Similarity: 0.63
[ 36745-93-4 ]
Methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate
Similarity: 0.60
[ 13162-26-0 ]
2,4-Dichloro-6-methyl-5-nitropyrimidine
Similarity: 0.79
[ 49845-33-2 ]
2,4-Dichloro-5-nitropyrimidine
Similarity: 0.72
[ 4359-87-9 ]
2,4,6-Trichloro-5-nitropyrimidine
Similarity: 0.66
[ 13162-43-1 ]
4,6-Dichloro-2-methyl-5-nitropyrimidine
Similarity: 0.61
[ 1445894-94-9 ]
2-Chloro-4-isopropoxy-5-nitropyrimidine
Similarity: 0.61
[ 54368-62-6 ]
Ethyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.85
[ 502184-51-2 ]
Methyl 5-amino-2,6-dichloropyrimidine-4-carboxylate
Similarity: 0.82
[ 13162-26-0 ]
2,4-Dichloro-6-methyl-5-nitropyrimidine
Similarity: 0.79
[ 49845-33-2 ]
2,4-Dichloro-5-nitropyrimidine
Similarity: 0.72
[ 51940-63-7 ]
Ethyl 6-chloropyrimidine-4-carboxylate
Similarity: 0.69